This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Traub, W. H. Articles by Fukushima, P. I. Search for Related Content PubMed PubMed Citation Articles by Traub, W. H. Articles by Fukushima, P. I.

Variable Neutralization of Several Nonspecific Antibacterial Systems in Fresh, Defibrinated Human Blood by Sodium Polyanetholsulfonate and Sodium Amylosulfate

Walter H. Traub^a, and Paula I. Fukushima¹

¹ Clinical Microbiology Laboratory, Clinical Pathology Service, Veterans Administration Medical Center, San Francisco, California 94141
^a Department of Laboratory Medicine, University of California, San Francisco, California 94143

ABSTRACT

Fresh, defibrinated human blood (80 vol%, i.e., 80% [vol/vol] of a 2-ml final assay volume) from two healthy adult donors killed "delayed serum-sensitive" (DSS) and "promptly serum-sensitive" (PSS) strains of Serratia marcescens, PSS control strain Escherichia coli C, Bacillus subtilis strain ATCC 6633, and Micrococcus lysodeikticus ATCC 4698 in a kinetic manner comparable to that of fresh human serum (80 vol%). However, heat-inactivated (56°C, 30 min), defibrinated human blood revealed markedly reduced or a total lack of ß-lysin activity against the B. subtilis assay strain. Similarly, lysozyme activity of defibrinated blood was diminished somewhat by heat treatment, as determined with the M. lysodeikticus assay strain. Addition of 500 µg of sodium polyanetholsulfonate (SPS) per ml to 80 vol% of fresh, defibrinated human blood completely neutralized blood bactericidal activity against all assay strains of S. marcescens, E. coli C, and B. subtilis; however, SPS at this concentration failed to abolish lysozyme activity for prolonged periods of incubation. Addition of 500 µg of sodium amylosulfate (SAS) per ml to 80 vol% of fresh defibtinated human blood resulted in protection of cell inocula of DSS strains of S. marcescens only; SAS failed to protect cell inocula of the PSS strains of S. marcescens, E. coli C, B. subtilis, and M. lysodeikticus for extended periods of observation. Based on these data, it is recommended that blood culture specimens that are first drawn into specimen containers (such as Vacutainer tubes or the like) at the patient's bedside, and which contain 250 µg of SPS per ml, be diluted into suitable broth media with at least 250 µg of SPS per ml by the receiving laboratory within 2 to 4 h after procurement of the specimen. This procedure would ensure continued, adequate neutralization of the specimen's inherent ß-lysin, lysozyme, and complement- and antibody-mediated bactericidal activities.

Present address: Institut für Hygiene und Mikrobiologie, Haus 43, 6650 Homburg/Saar, West Germany.

This article has been cited by other articles:

• Fredricks, D. N., Relman, D. A. (1998). Improved Amplification of Microbial DNA from Blood Cultures by Removal of the PCR Inhibitor Sodium Polyanetholesulfonate. J. Clin. Microbiol. 36: 2810-2816 [Abstract] [Full Text]